Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1422365-93-2
2. Hl-156a Free Base
3. Im156
4. Im156 Free Base
5. Hl156a Free Base
6. Im-156 Free Base
7. Hl271
8. 4g3buv6zsk
9. N-(n-(4-(trifluoromethoxy)phenyl)carbamimidoyl)pyrrolidine-1-carboximidamide
10. N'-[n'-[4-(trifluoromethoxy)phenyl]carbamimidoyl]pyrrolidine-1-carboximidamide
11. 1-pyrrolidinecarboximidamide, N-(imino((4-(trifluoromethoxy)phenyl)amino)methyl)-
12. N-(imino((4-(trifluoromethoxy)phenyl)amino)methyl)-1-pyrrolidinecarboximidamide
13. Chembl4650733
14. Schembl15830992
15. Schembl23035230
16. Dtxsid501336867
17. Ex-a4660
18. S9604
19. A936270
| Molecular Weight | 315.29 g/mol |
|---|---|
| Molecular Formula | C13H16F3N5O |
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | 315.13069464 g/mol |
| Monoisotopic Mass | 315.13069464 g/mol |
| Topological Polar Surface Area | 89.2 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 424 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A IM156 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of IM156, including repackagers and relabelers. The FDA regulates IM156 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. IM156 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A IM156 supplier is an individual or a company that provides IM156 active pharmaceutical ingredient (API) or IM156 finished formulations upon request. The IM156 suppliers may include IM156 API manufacturers, exporters, distributors and traders.
IM156 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of IM156 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right IM156 GMP manufacturer or IM156 GMP API supplier for your needs.
A IM156 CoA (Certificate of Analysis) is a formal document that attests to IM156's compliance with IM156 specifications and serves as a tool for batch-level quality control.
IM156 CoA mostly includes findings from lab analyses of a specific batch. For each IM156 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
IM156 may be tested according to a variety of international standards, such as European Pharmacopoeia (IM156 EP), IM156 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (IM156 USP).
LOOKING FOR A SUPPLIER?
